The Manila Times

AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing ...

Post-conference recap highlights direct anti-tumor effects in epithelial and non-epithelioid mesothelioma models, >90% tumor growth inhibition in vivo when TT-4 was combined with anti-PD-1, and ...
TipRanks on MSN

Genprex’s Innovative ES-SCLC Therapy: A Promising Clinical Update

Genprex (($GNPX)) announced an update on their ongoing clinical study. Genprex (GNPX) is conducting a clinical study titled ‘A Phase 1/2 Clinical ...
TipRanks on MSN

Radiopharm Theranostics Advances with Promising PD-L1 Targeted Therapy Study

Radiopharm Theranostics Limited (($AU:RAD)) announced an update on their ongoing clinical study. Study Overview: Radiopharm Theranostics Limited ...

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for ...